Trials have begun in the UK of the world's first personalized mRNA-based vaccine for melanoma treatment. This vaccine uses the unique genetic makeup of the patient's tumor, which significantly increases the chances of successful treatment.
Petersburg2 reports that the vaccine trains the body to recognize and destroy cancer cells, thus preventing the disease from recurring. The first results of using the vaccine showed that it significantly increases the chances of survival in the most aggressive form of skin cancer.
Scientists hope that the drug can also be used to fight lung, bladder, kidney and colon cancer.
A total of 1,100 patients worldwide will take part in the study. The drug stimulates a person's immune system so that it can effectively fight a specific type of cancer and tumor.
It was previously reported that plant-based foods reduce the risk of colon cancer, and the study also clarified the main cause of liver cancer.